fluorodeoxyglucose f18 has been researched along with liraglutide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bouchelouche, K; Bøtker, HE; Flyvbjerg, A; Harms, HJ; Iversen, P; Jorsal, A; Nielsen, R; Sørensen, J; Tolbod, L; Wiggers, H | 1 |
Binderup, T; Curovic, VR; Diaz, LJ; Hansen, TW; Jensen, JK; Kjaer, A; Ripa, RS; Rossing, P; von Scholten, BJ; Zobel, EH | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and liraglutide
Article | Year |
---|---|
Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
Topics: Aged; Cicatrix; Coronary Circulation; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Heart; Heart Failure; Humans; Liraglutide; Male; Metabolic Syndrome; Middle Aged; Myocardium; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Prediabetic State; Ventricular Dysfunction, Left | 2018 |
Effect of Liraglutide on Arterial Inflammation Assessed as [
Topics: Aged; Biomarkers; Blood Glucose; Carotid Artery Diseases; Carotid Intima-Media Thickness; Coronary Angiography; Coronary Artery Disease; Denmark; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Liraglutide; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Treatment Outcome; Vasculitis | 2021 |